Balaxi Pharmaceuticals fundamental analysis
BALAXI
27.94
0.17 (-0.60%)Last updated on 19 Dec, 2025 | 12:33 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Balaxi Pharmaceuticals Fundamentals
P/E Ratio
10.97
P/B Ratio
0.67
Div. Yield
0
Sector P/E
44.65
Sector P/B
2.7
Sec. Div. Yield
90.01
Balaxi Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 10.97, compared to the sector average of 44.65. Its P/B Ratio stands at 0.67, while the sector’s is 2.7. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 90.01%.
Balaxi Pharmaceuticals Score Card
Price
Attractive
Growth
Average
Quality
Good
Management
Good
On its scorecard, Balaxi Pharmaceuticals reflects: Price – Attractive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
